TherapeuticsMD Inc banner

TherapeuticsMD Inc
NASDAQ:TXMD

Watchlist Manager
TherapeuticsMD Inc Logo
TherapeuticsMD Inc
NASDAQ:TXMD
Watchlist
Price: 2.08 USD -0.48%
Market Cap: $24.1m

During the last 3 months TherapeuticsMD Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 17% over this period (open performance analysis).

The last transaction was made on Dec 23, 2025 by Thompson Tommy G , who bought 14k USD worth of TXMD shares.

Last Transactions:
Thompson Tommy G
$+14k
Thompson Tommy G
$+325.6
Walker Marlan D
$+489.3
Walker Marlan D
$+1k
Walker Marlan D
$+993.7
Collins Cooper C.
$+7.1k
Collins Cooper C.
$+2k
Walker Marlan D
$-10.2k
Walker Marlan D
$-33.5k
Walker Marlan D
$-4.3k
Donegan Michael C
$-249.4
Donegan Michael C
$-8.4k
Donegan Michael C
$-37.2
Donegan Michael C
$-7k
Rubric Capital Management Lp
$-38.7m
Bernick Brian
$-2k
Rubric Capital Management Lp
$+90.3k
Rubric Capital Management Lp
$+1.7k
Rubric Capital Management Lp
$+113.9k
Naughton Gail K
$-20.6k
Bernick Brian
$-4.6k
Walker Marlan D
$-5.2k
Glickman Mark A
$-2.2k
Donegan Michael C
$-4.3k
Rubric Capital Management Lp
$+7m
Rubric Capital Management Lp
$+7m
Rubric Capital Management Lp
$+2.7m
Rubric Capital Management Lp
$+106.7k
Rubric Capital Management Lp
$+360.8k
Donegan Michael C
$-319
Collins Cooper C.
$+11.6k
Collins Cooper C.
$+13k
View All Transactions

During the last 3 months TherapeuticsMD Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 17% over this period (open performance analysis).

The last transaction was made on Dec 23, 2025 by Thompson Tommy G , who bought 14k USD worth of TXMD shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
1
14k USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

TherapeuticsMD Inc
Insider Trading Chart

TherapeuticsMD Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

TherapeuticsMD Inc
Last Insider Transactions

Global
Insiders Monitor

TherapeuticsMD Inc
Glance View

Market Cap
24.1m USD
Industry
Pharmaceuticals

TherapeuticsMD, Inc. operates as a pharmaceutical company. The company is headquartered in Boca Raton, Florida and currently employs 416 full-time employees. The company went IPO on 2001-01-31. Its contraceptive products include ANNOVERA. ANNOVERA (segesterone acetate (SA) and ethinyl estradiol (EE) vaginal system) is a one-year ring-shaped contraceptive vaginal system (CVS) and patient-controlled, procedure-free, reversible prescription contraceptive. Its menopause portfolio includes IMVEXXY and BIJUV. IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia (vaginal pain associated with sexual activity), a symptom of vulvar and vaginal atrophy due to menopause. (estradiol and progesterone) capsules is a bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. Its prenatal vitamin products include vitaTrue, vitaPearl, and BocaGreenMD Prena1 True.

TXMD Intrinsic Value
Not Available

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett